bioRxiv · 10.1101/2025.03.31.646290
Associations between fluid biomarkers and PET imaging (UCB-J) of synaptic pathology in Alzheimer's disease
Abstract
INTRODUCTIONPositron Emission Tomography (PET) imaging with ligands for synaptic vesicle glycoprotein 2A (SV2A) has emerged as a promising methodology for measuring synaptic density in Alzheimers disease (AD). We investigate the relationship between SV2A PET and CSF synaptic protein changes of AD patients. METHODTwenty-one participants with early AD and 7 cognitively normal (CN) individuals underwent [11C]UCB-J PET. We used mass spectrometry to measure a panel of synaptic proteins in CSF. RESULTSIn the AD group, higher levels of syntaxin-7 and PEBP-1 were associated with lower global synaptic density. In the total sample, lower global synaptic density was associated with higher levels of AP2B1, neurogranin, {gamma}-synuclein, GDI-1, PEBP-1, syntaxin-1B, and syntaxin-7 but not with the levels of the neuronal pentraxins or 14-3-3 zeta/delta. CONCLUSIONReductions of synaptic density found in AD compared to CN participants using [11C]UCB-J PET were observed to be associated with CSF biomarker levels of synaptic proteins.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Nilsson, J., Mecca, A., Ashton, N. J., Salardini, E., Odell, R., Carson, R., Benedet, A., Blennow, K., Zetterberg, H., Van Dyck, C., Brinkmalm, A.. 2025-04-05. Associations between fluid biomarkers and PET imaging (UCB-J) of synaptic pathology in Alzheimer's disease. https://doi.org/10.1101/2025.03.31.646290
Cite the original work for its findings. Save a collection to share your selection of sources.